EN
CN
HOME
TEAM
PUBLICATIONS
EVENTS
RESOURCES
ACKNOWLEDGEMENTS
JOIN US
Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target
made with LayGridder